533 related articles for article (PubMed ID: 10873065)
41. C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
Nasu S; Ang KK; Fan Z; Milas L
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):474-7. PubMed ID: 11567823
[TBL] [Abstract][Full Text] [Related]
42. Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance.
Gupta VK; Jaskowiak NT; Beckett MA; Mauceri HJ; Grunstein J; Johnson RS; Calvin DA; Nodzenski E; Pejovic M; Kufe DW; Posner MC; Weichselbaum RR
Cancer J; 2002; 8(1):47-54. PubMed ID: 11895203
[TBL] [Abstract][Full Text] [Related]
43. Biological modifiers as potential radiosensitizers: targeting the epidermal growth factor receptor family.
Sartor CI
Semin Oncol; 2000 Dec; 27(6 Suppl 11):15-20; discussion 92-100. PubMed ID: 11236022
[TBL] [Abstract][Full Text] [Related]
44. Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7).
Pradier O; Rave-Fränk M; Schmidberger H; Bömecke M; Lehmann J; Meden H; Hess CF
J Cancer Res Clin Oncol; 1999; 125(1):20-7. PubMed ID: 10037273
[TBL] [Abstract][Full Text] [Related]
45. [Development of new treatment modalities for advanced head and neck carcinomas].
Tsukuda M
Gan To Kagaku Ryoho; 2001 Apr; 28(4):467-74. PubMed ID: 11329780
[TBL] [Abstract][Full Text] [Related]
46. Effects of antiepidermal growth factor receptor antibody 528 on the proliferation and differentiation of head and neck cancer.
Sturgis EM; Sacks PG; Masui H; Mendelsohn J; Schantz SP
Otolaryngol Head Neck Surg; 1994 Nov; 111(5):633-43. PubMed ID: 7970803
[TBL] [Abstract][Full Text] [Related]
47. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
[TBL] [Abstract][Full Text] [Related]
48. The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
Nowsheen S; Bonner JA; Yang ES
Radiother Oncol; 2011 Jun; 99(3):331-8. PubMed ID: 21719137
[TBL] [Abstract][Full Text] [Related]
49. Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck.
Allman R; Cowburn P; Mason M
Br J Cancer; 2000 Sep; 83(5):655-61. PubMed ID: 10944608
[TBL] [Abstract][Full Text] [Related]
50. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.
Weichselbaum RR; Dahlberg W; Beckett M; Karrison T; Miller D; Clark J; Ervin TJ
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2684-8. PubMed ID: 3458227
[TBL] [Abstract][Full Text] [Related]
51. Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2.
Yasumura S; Lin WC; Weidmann E; Hebda P; Whiteside TL
Int J Cancer; 1994 Oct; 59(2):225-34. PubMed ID: 7523315
[TBL] [Abstract][Full Text] [Related]
52. Treatment of head and neck and esophageal xenografts employing Alimta and concurrent ionizing radiation.
Mauceri HJ; Seetharam S; Salloum RM; Vokes EE; Weichselbaum RR
Int J Oncol; 2001 Oct; 19(4):833-5. PubMed ID: 11562763
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis.
Nguyen DM; Lorang D; Chen GA; Stewart JH; Tabibi E; Schrump DS
Ann Thorac Surg; 2001 Aug; 72(2):371-8; discussion 378-9. PubMed ID: 11515869
[TBL] [Abstract][Full Text] [Related]
54. Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells.
Ciardiello F; Damiano V; Bianco C; di Isernia G; Ruggiero A; Caraglia M; Tagliaferri P; Baselga J; Mendelsohn J; Bianco AR
Clin Cancer Res; 1995 Feb; 1(2):161-7. PubMed ID: 9815969
[TBL] [Abstract][Full Text] [Related]
55. Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.
van Gog FB; Brakenhoff RH; Stigter-van Walsum M; Snow GB; van Dongen GA
Int J Cancer; 1998 Jul; 77(1):13-8. PubMed ID: 9639387
[TBL] [Abstract][Full Text] [Related]
56. Optical imaging predicts tumor response to anti-EGFR therapy.
Helman EE; Newman JR; Dean NR; Zhang W; Zinn KR; Rosenthal EL
Cancer Biol Ther; 2010 Jul; 10(2):166-71. PubMed ID: 20505368
[TBL] [Abstract][Full Text] [Related]
57. Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein.
Seetharam S; Nodzenski E; Beckett MA; Heimann R; Cha A; Margulies I; Pastan I; Kufe DW; Weichselbaum RR
Cancer Res; 1998 Aug; 58(15):3215-20. PubMed ID: 9699644
[TBL] [Abstract][Full Text] [Related]
58. Angiogenic inhibition for the treatment of head and neck cancer.
Gleich LL; Zimmerman N; Wang YO; Gluckman JL
Anticancer Res; 1998; 18(4A):2607-9. PubMed ID: 9703916
[TBL] [Abstract][Full Text] [Related]
59. Molecular regulation of UVB-induced cutaneous angiogenesis.
Bielenberg DR; Bucana CD; Sanchez R; Donawho CK; Kripke ML; Fidler IJ
J Invest Dermatol; 1998 Nov; 111(5):864-72. PubMed ID: 9804351
[TBL] [Abstract][Full Text] [Related]
60. Antiproliferative effects of the biologically active metabolite of vitamin D3 (1,25 [OH]2 D3) on head and neck squamous cell carcinoma cell lines.
Kornfehl J; Formanek M; Temmel A; Knerer B; Willheim M
Eur Arch Otorhinolaryngol; 1996; 253(6):341-4. PubMed ID: 8858258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
